These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16008299)

  • 1. Tough cell to investors. Venture capitalists are wary of investing in companies in which risks in the science may not be rewarded by a health revenue stream.
    Moran N
    Sci Am; 2005 Jul; 293(1):A32-4. PubMed ID: 16008299
    [No Abstract]   [Full Text] [Related]  

  • 2. California dreaming.
    Nature; 2004 Oct; 431(7010):723. PubMed ID: 15483565
    [No Abstract]   [Full Text] [Related]  

  • 3. Australia's bio-regulatory framework: leading the way for stem cell research.
    Hill H
    J Biolaw Bus; 2004; 7(2):61-4. PubMed ID: 15460561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Companies balk at California's patent rules for stem cell research.
    Keim B
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem cells: science and society.
    Adusumilli PS; Tuorto S; Patel AN
    Natl Med J India; 2006; 19(1):47-8. PubMed ID: 16570690
    [No Abstract]   [Full Text] [Related]  

  • 6. Leaders and laggards in the stem cell enterprise.
    Herrera S
    Nat Biotechnol; 2005 Jul; 23(7):775-7. PubMed ID: 16003350
    [No Abstract]   [Full Text] [Related]  

  • 7. Critics slate ethical leeway in California stem-cell proposal.
    Knight J
    Nature; 2004 Sep; 431(7006):232. PubMed ID: 15371993
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology update: news and views.
    Debaets AM
    Ethics Med; 2005; 21(3):188-90. PubMed ID: 16475278
    [No Abstract]   [Full Text] [Related]  

  • 9. On the road to California.
    DeWitt N
    Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695
    [No Abstract]   [Full Text] [Related]  

  • 10. Schwarzenegger endorses stem-cell push.
    Knight J
    Nature; 2004 Oct; 431(7011):888. PubMed ID: 15496884
    [No Abstract]   [Full Text] [Related]  

  • 11. California prepares to roll out stem-cell funding.
    Dalton R
    Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
    [No Abstract]   [Full Text] [Related]  

  • 12. Stem cells. Court rules in favor of California stem cell institute.
    Kaiser J
    Science; 2006 Apr; 312(5773):509. PubMed ID: 16645055
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges anticipated in removal of stem cell restrictions.
    Hutson S
    Nat Med; 2009 Jan; 15(1):3. PubMed ID: 19129765
    [No Abstract]   [Full Text] [Related]  

  • 14. California makes unprecedented commitment to fund stem cell research.
    Willard LA
    J Biolaw Bus; 2005; 8(2):47-8. PubMed ID: 16538814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From science to politics: the stem cell debate.
    Jennings CP
    Policy Polit Nurs Pract; 2005 Feb; 6(1):3-4. PubMed ID: 16443952
    [No Abstract]   [Full Text] [Related]  

  • 16. Joys match fears as California agrees to stem-cell proposal.
    Knight J
    Nature; 2004 Nov; 432(7014):135. PubMed ID: 15538329
    [No Abstract]   [Full Text] [Related]  

  • 17. The stem-cell state.
    Nature; 2004 Nov; 432(7014):131. PubMed ID: 15538323
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem-cell issue moves up the US agenda.
    Wadman M
    Nature; 2007 Apr; 446(7138):842. PubMed ID: 17443152
    [No Abstract]   [Full Text] [Related]  

  • 19. California Stem Cell Research and Cures Act: what to expect from stem cell research?
    Panetta J; Wetherell J; Mehok M
    J Biolaw Bus; 2005; 8(4):3-12. PubMed ID: 16619447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Europe halts decisions on stem-cell patents.
    Schubert S
    Nature; 2005 Jun; 435(7043):720-1. PubMed ID: 15944658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.